Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study

Autor: Eisenberger, Ute, Budde, Klemens, Mühlfeld, Anja, Hauser, Ingeborg A., Nadalin, Silvio, Porstner, Martina, Arns, Wolfgang, ZEUS Study Investigators, Lehner, Frank, Klempnauer, Jürgen, Neumayer, Hans-H., Gerke, Peter, Klehr, Hans Ulrich, Mühlfeld, Anja Susanne, Witzke, Oliver, Pietruck, Frank, Heller, Katharina, Reinke, Petra, Senninger, Norbert, Sommerer, Claudia, Wolters, Heiner H., Suwelack, Barbara, Zeier, Martin, Stahl, Rolf, Thorban, Stefan, Stangl, Manfred, Steurer, Wolfgang, Frey, Felix, Wüthrich, Rudolf P., Clavien, Pierre-Alain

Publikováno v: BMC Nephrology, Vol 19, Iss 1, Pp 1-8 (2018)
BMC nephrology 19(1), 154 (2018). doi:10.1186/s12882-018-0950-1
BMC Nephrology

Background Conversion from calcineurin inhibitor (CNI) therapy to everolimus within 6 months after kidney transplantation improves long-term graft function but can increase the risk of mild biopsy-proven acute cellular rejection (BPAR). We performed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c2419514b347a116b53f4065cb529b
https://doi.org/10.1186/s12882-018-0950-1

ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus

Autor: Rummo, Oleg O., Carmellini, Mario, Rostaing, Lionel, Oberbauer, Rainer, Christiaans, Maarten H. L., Mousson, Christiane, Langer, Robert M., Citterio, Franco, Charpentier, Bernard, Brown, Malcolm, Kazeem, Gbenga, Lehner, Frank, Heer, Munish, Lim, Wai, Mühlbacher, Ferdinand, Pratschke, Johann, Bonvoisin, Cathérine, Kuypers, Dirk, Dedochova, Jarmila, Kuman, Milan, Le Meur, Yann, Deteix, Patrice, Frimat, Luc, Lang, Philippe, Lebranchu, Yvon, Legendre, Christophe, Westeel, Pierre Francois, Schenker, Peter, Hilgers, Karl-Friedrich, Witzke, Oliver, Hauser, Ingeborg, Kliem, Volker, Zeier, Martin, Kunzendorf, Ulrich, Bartels, Michael, Jonas, Sven, Guba, Markus, Wolters, Heiner H., Chan, Tak-Mao, Caputo, Flavia, Sparacino, Vito, Nowicki, Michal, Glyda, Maciej, Kim, Yu Seun, Jongwon, Ha, Kim, Chan Duck, Han, Duck Jong, Kim, Yeong Hoon, Perlin, Dmitry, Sal'Mayer, Alexander, Semchenko, Sergey B., Nesterenko, Igor, Franco, Antonio, Grinyó, Josep, Inza, Ainhoa, Ruiz, Juan Carlos, Chiang, Yang-Jen, Lee, Po-Chang, Suleymanlar, Gultekin, Sevmis, Sinasi, Kacar, Serdar

Publikováno v: Transplant International
Transplant International, Wiley, 2017, 30 (1), pp.83-95. ⟨10.1111/tri.12878⟩
Transplant International 2017; 30: 83-95
UCrea Repositorio Abierto de la Universidad de Cantabria
Universidad de Cantabria (UC)
Transplant International, 30(1), 83-95. Wiley

ADHERE was a randomized, open-label, Phase IV study comparing renal function at Week 52 postkidney transplant, in patients who received prolonged-release tacrolimus-based immunosuppressive regimens. On Days 0-27, patients received prolonged-release t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::387885bb2c37dccfae57279f8f01911e
https://hal.archives-ouvertes.fr/hal-01529267

Efficacy and safety of conversion from cyclosporine to everolimus in living-donor kidney transplant recipients : an analysis from the ZEUS study

Autor: Lehner, Frank, Budde, Klemens, Zeier, Martin, Wüthrich, Rudolf P, Reinke, Petra, Eisenberger, Ute, Mühlfeld, Anja, Arns, Wolfgang, Stahl, Rolf, Heller, Katharina, Witzke, Oliver, Wolters, Heiner H, Suwelack, Barbara, Klehr, Hans Ulrich, Stangl, Manfred, Hauser, Ingeborg A, Nadalin, Silvio, Porstner, Martina, May, Christoph, Paulus, Eva-Maria, Sommerer, Claudia, ZEUS Study Investigators

Conversion of living-donor kidney transplant patients from calcineurin inhibitor therapy to an mTOR inhibitor is poorly documented. In the prospective, multicentre ZEUS study, 300 kidney transplant recipients without prior rejection (Banff grade >1)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d5764948aeecf804186bd5b0249db758
https://www.ncbi.nlm.nih.gov/pubmed/25070687

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.